Suppr超能文献

加速针对 RNA 的药物发现:探索 RNA-小分子对的迭代“RNA 选择-化合物筛选循环”。

Speeding drug discovery targeting RNAs: An iterative "RNA selection-compounds screening cycle" for exploring RNA-small molecule pairs.

机构信息

Department of Regulatory Bioorganic Chemistry, The Institute of Scientific and Industrial Research, Osaka University, 8-1 Mihogaoka, Ibaraki 567-0047, Japan; Chemical Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco INC., 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.

Department of Regulatory Bioorganic Chemistry, The Institute of Scientific and Industrial Research, Osaka University, 8-1 Mihogaoka, Ibaraki 567-0047, Japan.

出版信息

Bioorg Med Chem. 2021 Apr 15;36:116070. doi: 10.1016/j.bmc.2021.116070. Epub 2021 Feb 18.

Abstract

RNA is an emerging target of next-generation drug development. Recently, new small molecules targeting RNAs were discovered by several pharmaceutical companies. Methods have been reported to identify small molecules targeting a specific RNA sequence and structural motif, however, because of diverse sequence and structural motifs potentially present in the druggable functional RNAs, large sets of structure-activity relationships (SARs) information of small molecule - RNA interactions will be required for the acceleration and efficient startup of the discovery programs toward unprecedented RNA targets. Here we describe our iterative RNA selection and compounds screening to accumulate rich information about small molecules - RNA interaction. The RNAs that selectively bind to the initial molecular target, compound 1 from our in-house chemical library (JT-library), was isolated using in vitro selection technique from a hairpin-structured RNA library mimicking precursor microRNA (pre-miRNA). Then, we engineered pre-let-7f-2 to create its mutant that can bind to compound 1 by embedding the in vitro selected RNA motif for compound 1 in the hairpin loop region. The obtained mutant pre-let-7f-2-loop-mt was used as a target for screening 316 analogs of compound 1. A surface plasmon resonance (SPR) -based screening was performed against pre-let-7f-2-loop-mt-immobilized sensor surface and we obtained four compounds that can bind to the RNA. Among these four compounds, three compounds showed higher affinity to pre-let-7f-2-loop-mt than the parental compound 1, which suggests the feasibility of our strategy for gathering the SAR information on small molecule - RNA interactions. We demonstrated only one cycle of RNA selection and compounds screening in the present study, but can continue this cycle with the selected molecule to gain new RNAs and even new RNA motifs and gather much SAR information with improved accuracy.

摘要

RNA 是下一代药物开发的新兴靶点。最近,几家制药公司发现了几种针对 RNA 的新型小分子。已经报道了鉴定针对特定 RNA 序列和结构模体的小分子的方法,但是,由于潜在的可成药功能 RNA 中存在多样化的序列和结构模体,因此需要大量小分子-RNA 相互作用的构效关系 (SAR) 信息,以加速和有效地启动针对前所未有的 RNA 靶点的发现计划。在这里,我们描述了我们的迭代 RNA 选择和化合物筛选方法,以积累有关小分子-RNA 相互作用的丰富信息。使用体外选择技术从模拟前体 microRNA (pre-miRNA) 的发夹结构 RNA 文库中分离出与初始分子靶标(来自我们内部化学文库 (JT-library) 的化合物 1)选择性结合的 RNA。然后,我们设计了 pre-let-7f-2,通过将用于化合物 1 的体外选择 RNA 基序嵌入发夹环区域,创建了可以与化合物 1 结合的突变体。获得的突变体 pre-let-7f-2-loop-mt 被用作筛选化合物 1 的 316 个类似物的靶标。针对固定在 pre-let-7f-2-loop-mt-immobilized 传感器表面上的靶标进行了表面等离子体共振 (SPR) 筛选,我们获得了 4 种可以与 RNA 结合的化合物。这 4 种化合物中,有 3 种化合物与 pre-let-7f-2-loop-mt 的结合亲和力高于母体化合物 1,这表明了我们在收集小分子-RNA 相互作用的 SAR 信息方面的策略的可行性。在本研究中,我们仅展示了一个 RNA 选择和化合物筛选循环,但可以继续使用所选分子进行下一个循环,以获得新的 RNA 甚至新的 RNA 基序,并以更高的准确性收集更多的 SAR 信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验